tiprankstipranks
Trending News
More News >
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
India Market

Sun Pharma Advanced Research Co. Ltd. (SPARC) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

SPARC Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Sun
Pharma Advanced Research Co. Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SPARC Stock 12 Month Forecast

There Are No Analyst Ratings for IN:SPARC In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SPARC Financial Forecast

SPARC Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

SPARC Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on IN:SPARC
TipRanks - DeepSeek
TipRanks - DeepSeek
₹125₹126
Hold
-7.15%
Downside
Reiterated
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on IN:SPARC
TipRanks - xAI
TipRanks - xAI
₹126₹128
Hold
-5.67%
Downside
Reiterated
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on IN:SPARC
TipRanks - PerPlexity
TipRanks - PerPlexity
₹118₹119
Sell
-12.31%
Downside
Downgraded
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on IN:SPARC
TipRanks - Google
TipRanks - Google
₹128₹129
Hold
-4.94%
Downside
Upgraded
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on IN:SPARC
TipRanks - OpenAI
TipRanks - OpenAI
₹122₹123
Hold
-9.36%
Downside
Reiterated
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on IN:SPARC
TipRanks - Anthropic
TipRanks - Anthropic
₹126₹128
Hold
-5.67%
Downside
Upgraded
01/31/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on IN:SPARC
TipRanks - DeepSeek
TipRanks - DeepSeek
₹125₹126
Hold
-7.15%
Downside
Reiterated
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on IN:SPARC
TipRanks - xAI
TipRanks - xAI
₹126₹128
Hold
-5.67%
Downside
Reiterated
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on IN:SPARC
TipRanks - PerPlexity
TipRanks - PerPlexity
₹118₹119
Sell
-12.31%
Downside
Downgraded
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on IN:SPARC
TipRanks - Google
TipRanks - Google
₹128₹129
Hold
-4.94%
Downside
Upgraded
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on IN:SPARC
TipRanks - OpenAI
TipRanks - OpenAI
₹122₹123
Hold
-9.36%
Downside
Reiterated
01/31/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on IN:SPARC
TipRanks - Anthropic
TipRanks - Anthropic
₹126₹128
Hold
-5.67%
Downside
Upgraded
01/31/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sun Pharma Advanced Research Co. Ltd.

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+10.90%
downgraded a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.90% per trade.
1 Year
PerPlexity Health Care INTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+10.90%
downgraded a sell rating 3 days ago
Copying PerPlexity Health Care IN's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.90% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+10.90%
downgraded a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SPARC Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, SPARC has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SPARC average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

SPARC Stock Forecast FAQ

What is IN:SPARC’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:SPARC’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:SPARC, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Sun Pharma Advanced Research Co. Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Sun Pharma Advanced Research Co. Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Sun Pharma Advanced Research Co. Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Sun Pharma Advanced Research Co. Ltd.?
      To buy shares of IN:SPARC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.